ARIX.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 vas. 2024 @ 19:15):

Stats
Dzisiejszy wolumen	13.86M
Średni wolumen	462 154
Kapitalizacja rynkowa	183.73M
EPS	£0 ( 2024-04-22 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	12.91
ATR14	£2.89 (2.03%)

Wolumen Korelacja

Długi: 0.24 (neutral)

Krótki: -0.87 (strong negative)

Signal:(69.448) Neutral

Arix Bioscience PLC Korelacja

10 Najbardziej pozytywne korelacje
JUSC.L	0.918
FLO.L	0.886
ADVT.L	0.871
EPWN.L	0.863
ALU.L	0.842
ATS.L	0.836
AHT.L	0.832
MTR.L	0.831
SLI.L	0.829
TBCG.L	0.828

10 Najbardziej negatywne korelacje
TRS3.L	-0.842
MDBG.L	-0.819
PHPM.L	-0.815
DDBG.L	-0.806

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Arix Bioscience PLC Korelacja - Waluta/Towar

0.42
( neutral )

0.84
( strong )

0.39
( neutral )

0.66
( moderate )

-0.86
( strong negative )

-0.39
( neutral )

Arix Bioscience PLC Finanse

Annual	2022
Przychody:	£112 000
Zysk brutto:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2022
Przychody:	£112 000
Zysk brutto:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2021
Przychody:	£340 000
Zysk brutto:	£0.00 (0.00 %)
EPS:	£-0.582

FY	2020
Przychody:	£477 000
Zysk brutto:	£0.00 (0.00 %)
EPS:	£0.968

Financial Reports:

No articles found.

Arix Bioscience PLC

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.